PAYVANDI, FLORA
PAYVANDI, FLORA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Gene therapy in hemophilia: the dawn of a new era
2025 R. Gualtierotti, A. Giachi, N. Bitto, V. La Mura, F. Peyvandi
Reappraisal of the conventional hemostasis tests as predictors of perioperative bleeding in the era of rebalanced hemostasis in cirrhosis
2024 A. Tripodi, M. Primignani, R. D'Ambrosio, G. Tosetti, V. La Mura, P. Lampertico, F. Peyvandi
Clinical and Laboratory Presentation and Underlying Mechanism in Patients with Low VWF
2024 O. Seidizadeh, A. Ciavarella, L. Baronciani, F. Boggio, F. Ballardini, G. Cozzi, P. Colpani, M.T. Pagliari, C. Novembrino, S.M. Siboni, F. Peyvandi
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database
2024 S. Mohsenian, R. Palla, M. Menegatti, A. Cairo, A. Lecchi, A. Casini, M. Neerman-Arbez, R. Asselta, S. Scardo, S.M. Siboni, J. Blatny, O. Zapletal, J. Schved, M. Giansily-Blaizot, S. Halimeh, M.A. Daoud, H. Platokouki, H. Pergantou, R.E.G. Schutgens, M. Van Haaften-Spoor, P. Brons, B. Laros-van Gorkom, E. Van Pinxten, M. Borhany, N. Fatima, D. Mikovic, M. Saracevic, G.N. Özdemir, Y. Ay, M. Makris, C. Lockley, A. Mumford, A. Harvey, S. Austin, A. Shapiro, A. Williamson, C. Mcguinn, I. Goldberg, P. De Moerloose, F. Peyvandi
Administration of gene therapy for haemophilia – The hub and spoke model and its regional differences and challenges
2024 W. Miesbach, A. Boban, P. Chowdary, M. Coppens, M. Crato, V. Jimenez‐yuste, R. Klamroth, M. Makris, G. Mulders, F. Peyvandi
Landmark endorsement of a global registry: The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP), publicly endorses World Federation of Hemophilia Gene Therapy Registry as global standard
2024 B.A. Konkle, F. Peyvandi, D. Coffin, M. Naccache, T. Youttananukorn, G.F. Pierce
Evaluation of an automated platelet aggregation method for detection of congenital or acquired platelet function defects
2024 A. Lecchi, M. Capecchi, L. Padovan, A. Artoni, N. Arai, S. Shinohara, S. La Marca, F. Peyvandi
A case of lymphadenopathies with concomitant multiple acquired hemostasis disorders in an adult female patient
2024 A. Truma, A. Artoni, J.A. Giannotta, M. Caronni, F. Peyvandi
Comparative Investigation of Thromboelastometry and Thrombin Generation for Patients Receiving Direct Oral Anticoagulants or Vitamin K Antagonists
2024 A. Tripodi, M. Capecchi, E. Scalambrino, M. Clerici, B. Scimeca, P. Agosti, P. Bucciarelli, A. Artoni, F. Peyvandi
Recommendations for a minimum data set for monitoring gene therapy in hemophilia: communication from the ISTH SSC Working Group on Gene Therapy
2024 W. Miesbach, B. Konkle, P. Chowdary, R. Kaczmarek, F. Leebeek, J. Mahlangu, M. Makris, S.W. Pipe, A. Srivastava, J. Voorberg, G.F. Pierce, F. Peyvandi
Gut Microbiome Diversity and Composition Correlates With Time in the Therapeutic Range in Patients on Warfarin Treatment: A Pilot Study
2024 P. Agosti, A. Kouraki, T. Dionisi, G. Addolorato, L. D'Innocenzo, S. Sorrentino, F. De Maio, E. De Candia, A. Blanco-Miguez, D. Bazzani, A. Bonadiman, G. Tonidandel, M. Bolzan, F. Gianniello, S.M. Passamonti, M. Abbattista, A.M. Valdes, P. Bucciarelli, F. Peyvandi, C. Menni
Gene therapy for people with Haemophilia B: a proposed care delivery model in Italy
2024 G. Castaman, G. Di Minno, P. Simioni, A.C. Molinari, S. Siragusa, E. Baldacci, V. La Mura, A. Lupi, E.F. Grazzi, F. Peyvandi
Caplacizumab improves clinical outcomes and is well tolerated across clinically relevant subgroups of patients with immune-mediated thrombotic thrombocytopenic purpura
2024 K. Pavenski, M. Scully, P. Coppo, S. Cataland, P. Knöbl, F. Peyvandi, J.A. Kremer Hovinga, J. de la Rubia, U. Khan, A.P. Marques, S. Gunawardena
Optimizing long-term joint health in the treatment of hemophilia
2024 R. Gualtierotti, A. Giachi, C. Suffritti, L. Bedogni, F. Franco, F. Poggi, S. Mascetti, M. Colussi, D. Ahmetovic, V. Begnozzi, E.A. Boccalandro, L.P. Solimeno, F. Peyvandi
Application of genetic testing for the diagnosis of von Willebrand disease
2024 O. Seidizadeh, L. Baronciani, D. Lillicrap, F. Peyvandi
Main features of ischemic stroke in patients with acute immune-mediated thrombotic thrombocytopenic purpura
2024 A. Truma, I. Mancini, P. Agosti, A. Artoni, J.A. Giannotta, B. Ferrari, P. De Leo, F. Peyvandi
IgM autoantibodies to complement factor H in C3 glomerulopathy
2024 M. Cugno, M.C. Mancuso, F. Depetri, F. Peyvandi, G. Ardissino
Gender equity in hemophilia: need for healthcare, familial, and societal advocacy
2024 R. Gualtierotti, I. Garagiola, M. Mortarino, S. Spena, O. Romero-Lux, F. Peyvandi
Variant p.Tyr1584Cys: a frequent von Willebrand factor variant in search of von Willebrand disease
2024 O. Seidizadeh, L. Baronciani, P. Colpani, G. Cozzi, A. Ciavarella, S.M. Siboni, F. Peyvandi
How the Hemostasis Laboratory can Help Clinicians to Manage Patients on Oral Anticoagulants
2024 A. Tripodi, M. Clerici, E. Scalambrino, P. Agosti, P. Bucciarelli, F. Peyvandi